Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-24-006020
Filing Date
2024-01-31
Accepted
2024-01-31 14:08:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 us87990a1060_013124.txt SC 13G 11595
  Complete submission text file 0001086364-24-006020.txt   13442
Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92757 | Film No.: 24582140
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)